<?xml version="1.0" encoding="UTF-8"?><rss version="2.0">
	<channel>
		<title>SeouLin Bioscience</title>
		<link>https://en.seoulin.co.kr</link>
		<description>HOCl. Sterilization Water generator, Research reagents, Equipment and Materials, HOCl generator korea, Hypochlorous Acid Water</description>
		
				<item>
			<title><![CDATA[BUCHI]]></title>
			<link><![CDATA[https://en.seoulin.co.kr/?kboard_content_redirect=112]]></link>
			<description><![CDATA[<div style="font-family:Pretendard, 'Noto Sans KR', Arial, sans-serif;color:#1b2937;line-height:1.55;margin:0 auto;">
<p style="margin:0 0 12px 0;"><strong>About BUCHI</strong>
<strong>“Quality in your hands”</strong> — BUCHI delivers quality and reliability in every customer’s hands.
With over 85 years of expertise and innovation, BUCHI provides advanced laboratory and production solutions trusted by professionals worldwide.</p>
<p style="margin:12px 0;">Serving diverse industries such as <strong>chemistry, pharmaceuticals, food, and environmental sciences,</strong>
BUCHI offers high-performance equipment and integrated solutions for <strong>evaporation, separation, analysis, and drying applications.</strong>
Our user-centered design philosophy and global service network enhance research efficiency, precision, and safety.</p>
<p style="margin:12px 0;">Beyond supplying instruments, BUCHI strives to be a <strong>sustainable partner in quality and innovation,</strong>
committed to supporting our customers’ success through continuous improvement and technical excellence.</p>

<div style="text-align:center;margin-top:20px;"><a style="padding:10px 24px;background-color:#4caf50;color:#ffffff;font-weight:600;text-decoration:none;" href="https://buchi.com/" target="_blank">Visit BUCHI Homepage
</a></div>
</div>]]></description>
			<author><![CDATA[sln_admin]]></author>
			<pubDate>Wed, 15 Oct 2025 09:58:22 +0000</pubDate>
			<category domain="https://en.seoulin.co.kr/?kboard_redirect=2"><![CDATA[Partners]]></category>
		</item>
				<item>
			<title><![CDATA[InVitira]]></title>
			<link><![CDATA[https://en.seoulin.co.kr/?kboard_content_redirect=111]]></link>
			<description><![CDATA[<strong>Performance. Defined.</strong>

InVitira is dedicated to transforming life sciences and biomanufacturing with high-quality, recombinant, and animal-origin-free (AOF) ingredients that drive process efficiency, reliability, and scalability. From cutting-edge therapeutics and diagnostics to regenerative medicine, our chemically-defined solutions meet the highest industry standards, empowering researchers and manufacturers to innovate safely and effectively. InVitria’s products support every step from discovery to commercial production, ensuring precision, compliance, and the potential for life-saving advancements across pharmaceutical, vaccine, and biologics manufacturing.

<a style="padding:12px 24px;background-color:#21409a;color:#ffffff;text-decoration:none;font-weight:bold;" href="https://invitria.com/" target="_blank">InVitria Homepage
</a>]]></description>
			<author><![CDATA[sln_admin]]></author>
			<pubDate>Tue, 15 Jul 2025 14:54:36 +0000</pubDate>
			<category domain="https://en.seoulin.co.kr/?kboard_redirect=2"><![CDATA[Partners]]></category>
		</item>
				<item>
			<title><![CDATA[Biosesang]]></title>
			<link><![CDATA[https://en.seoulin.co.kr/?kboard_content_redirect=110]]></link>
			<description><![CDATA[<h4><a href="http://biosesang.co.kr/site/company" target="_blank"><strong>Biosesang Homepage⇒</strong></a></h4>]]></description>
			<author><![CDATA[sln_admin]]></author>
			<pubDate>Fri, 27 Dec 2024 11:00:16 +0000</pubDate>
			<category domain="https://en.seoulin.co.kr/?kboard_redirect=2"><![CDATA[Partners]]></category>
		</item>
				<item>
			<title><![CDATA[BIOSPEC]]></title>
			<link><![CDATA[https://en.seoulin.co.kr/?kboard_content_redirect=109]]></link>
			<description><![CDATA[BioSpec Products has provided innovative laboratory equipment for 40 years. Most of our products are of our design. And, many are industry "firsts." For example, it was our Mini-Beatbeater line that founded the popular cell and tissue disruption method now commonly refered to as "beadbeating".
We concentrate on developing quality products priced at affordable prices. Customer care is one of our specialties. Please contact us for sound, informed advice.
<h4><a href="https://biospec.com/" target="_blank"><strong>BIOSPEC Homepage⇒</strong></a></h4>]]></description>
			<author><![CDATA[sln_admin]]></author>
			<pubDate>Fri, 27 Dec 2024 10:49:58 +0000</pubDate>
			<category domain="https://en.seoulin.co.kr/?kboard_redirect=2"><![CDATA[Partners]]></category>
		</item>
				<item>
			<title><![CDATA[Waken]]></title>
			<link><![CDATA[https://en.seoulin.co.kr/?kboard_content_redirect=108]]></link>
			<description><![CDATA[Waken B Tech Co., Ltd. now specialize in cell culture related equipment and consumables and have entered into areas such as the supply of equipment to pharmaceutical and bio-pharmaceutical companies as well as vaccine manufacturing plants and all the related research areas.
Waken B Tech Co., Ltd. have reorganized divisions and after March 2012 our group companies including such as WAKENYAKU Co., Ltd became part of a new holdings company WAKEN Holdings., LTD.

<a href="https://www.wakenbtech.co.jp/eng/" target="_blank">Waken Homepage</a>]]></description>
			<author><![CDATA[sln_admin]]></author>
			<pubDate>Fri, 27 Dec 2024 10:47:52 +0000</pubDate>
			<category domain="https://en.seoulin.co.kr/?kboard_redirect=2"><![CDATA[Partners]]></category>
		</item>
				<item>
			<title><![CDATA[Azenta]]></title>
			<link><![CDATA[https://en.seoulin.co.kr/?kboard_content_redirect=107]]></link>
			<description><![CDATA[Azenta is a life science research and development company that standardizes processes from lab to patient.  Our award-winning products enable researchers, clinicians and manufacturers to protect temperature-sensitive therapeutics, biological samples and biomaterials.  By addressing temperature stability, Azenta strives to improve the success of therapeutic discovery and enable effective care delivery.
<h4><a href="https://www.azenta.com/" target="_blank"><strong>Azenta Homepage⇒</strong></a></h4>]]></description>
			<author><![CDATA[sln_admin]]></author>
			<pubDate>Fri, 27 Dec 2024 10:42:14 +0000</pubDate>
			<category domain="https://en.seoulin.co.kr/?kboard_redirect=2"><![CDATA[Partners]]></category>
		</item>
				<item>
			<title><![CDATA[Fapon]]></title>
			<link><![CDATA[https://en.seoulin.co.kr/?kboard_content_redirect=106]]></link>
			<description><![CDATA[Fapon Biotech Inc., founded in 2001, adheres to the mission of “Enable Disease Identification Earlier, More Accurate, Convenient and Affordable”, while focusing on the future needs and trends of biotechnology development, and committed to providing global diagnostic companies with high-performance IVD reagent raw materials, such as antigens, antibodies, and enzymes, as well as reagent solutions and innovative open instrument platforms. Our products and services are highly integrated, promoting synergic resources and shared-values to the industry, making the developments of diagnostic technologies benefiting more people, advancing the cause of human health.
<h4><a href="https://en.faponbiotech.com/" target="_blank"><strong>Fapon Homepage⇒</strong></a></h4>]]></description>
			<author><![CDATA[sln_admin]]></author>
			<pubDate>Fri, 27 Dec 2024 10:32:46 +0000</pubDate>
			<category domain="https://en.seoulin.co.kr/?kboard_redirect=2"><![CDATA[Partners]]></category>
		</item>
				<item>
			<title><![CDATA[Cell Signaling Technology]]></title>
			<link><![CDATA[https://en.seoulin.co.kr/?kboard_content_redirect=105]]></link>
			<description><![CDATA[Cell Signaling Technology (CST) is a <em>different</em> kind of life sciences company—one founded, owned, and run by active research scientists, with the highest standards of product and service quality, technological innovation, and scientific rigor. CST consistently provide fellow scientists around the globe with best-in-class products and services to fuel their quests for discovery. CST is a company of caring people driven by a devotion to facilitating good science—a company committed to doing the right thing for our Customers, our communities, and our planet.]]></description>
			<author><![CDATA[sln_admin]]></author>
			<pubDate>Fri, 27 Dec 2024 10:25:54 +0000</pubDate>
			<category domain="https://en.seoulin.co.kr/?kboard_redirect=2"><![CDATA[Partners]]></category>
		</item>
				<item>
			<title><![CDATA[Nova Biomedical(Advanced Instruments )]]></title>
			<link><![CDATA[https://en.seoulin.co.kr/?kboard_content_redirect=104]]></link>
			<description><![CDATA[Nova Biomedical(Advanced Instruments ) is a global provider of scientific and analytical solutions for the bioprocessing and clinical industries. Since 1955, the company’s innovations have helped organizations improve quality of results, achieve reliable outcomes, and increase workplace productivity. Its newest addition, the Artel portfolio, includes leading analytical instruments, software and services that validate, automate, and calibrate critical liquid handling processes and instrumentation. The Solentim portfolio delivers best-in-class imaging and single-cell deposition technologies for cell line development workflows. Its OsmoTECH<sup>®</sup> and OsmoPRO<sup>®</sup> micro-osmometers support the workflows that labs worldwide rely on for the delivery of accurate and timely results.

<a href="https://www.novabiomedical.com/" target="_blank"><span style="color:#3366ff;font-size:20px;"><strong>Nova Biomedical(Advanced Instruments ) Homepage⇒</strong></span></a>]]></description>
			<author><![CDATA[sln_admin]]></author>
			<pubDate>Fri, 27 Dec 2024 10:23:19 +0000</pubDate>
			<category domain="https://en.seoulin.co.kr/?kboard_redirect=2"><![CDATA[Partners]]></category>
		</item>
				<item>
			<title><![CDATA[SeouLin Bioscience signed a partnership with Becton Dickinson and Company]]></title>
			<link><![CDATA[https://en.seoulin.co.kr/?kboard_content_redirect=102]]></link>
			<description><![CDATA[SeouLin Bioscience (hereinafter SeouLin Bio) signed a partnership contract with Becton Dickinson and Company (hereinafter BD).
According to an official from SeouLin Bio, the company recently signed a partnership contract with BD, a global company located in New Jersey, US. BD is a healthcare company that provides medical technology solutions such as medical research, genomics, infectious diseases, cancer diagnosis, and infection prevention.
SeouLin Bio has supplied flow cytometry equipment and reagents to domestic bio researchers through this partnership.
Flow cytometry is a rapid analysis technique of various cells and beads with particle properties in a fluid state. It can be applied to △Stem cell formation and differentiation research △Immune cell characteristics and function research, △Gene expression, △Microorganism research, △Microorganism measurement quality control and water quality control.
SeouLin Bio said, “Through this contract, we will supply high-end products to bio companies, university research centers. We expect to increase our sales by strengthening sales network with the new hospital customers that diagnoses patient’s disease.”

[fn종목 돋보기] 서린바이오, 글로벌 브랜드 'BD'와 파트너십 체결 "매출 확대 기대" 파이낸셜뉴스 last modified June 3, 2021, accessed July 1, 2021,

<a href="https://www.fnnews.com/news/202106031314234755">https://www.fnnews.com/news/202106031314234755</a>]]></description>
			<author><![CDATA[seoulin]]></author>
			<pubDate>Thu, 01 Jul 2021 11:00:16 +0000</pubDate>
			<category domain="https://en.seoulin.co.kr/?kboard_redirect=1"><![CDATA[SLB NEWS]]></category>
		</item>
				<item>
			<title><![CDATA[Nordmark Pharma GmbH]]></title>
			<link><![CDATA[https://en.seoulin.co.kr/?kboard_content_redirect=94]]></link>
			<description><![CDATA[<p style="margin:1.84em 0px .92em;padding:0px;border:0px;color:#666666;text-transform:none;line-height:1.3846;text-indent:0px;letter-spacing:normal;clear:both;font-family:'Titillium Web', 'Noto Sans', 'sens-serif';font-style:normal;font-weight:bold;word-spacing:0px;vertical-align:baseline;white-space:normal;background-color:#ffffff;"><span style="font-family:arial, helvetica, sans-serif;font-size:18pt;">WE ARE FLEXIBLE, INDEPENDENT AND GLOBALLY ACTIVE</span></p>
<span style="color:#666666;text-transform:none;text-indent:0px;letter-spacing:normal;font-family:'Titillium Web', 'Noto Sans', 'sens-serif';font-size:16px;font-style:normal;font-weight:400;word-spacing:0px;float:none;white-space:normal;background-color:#ffffff;">Nordmark is a medium sized, owner-managed company founded in 2001 as the result of a management buyout from the BASF Group. Inspired by the organisation and high quality standards  of our former parent company, as an independent pharmaceutical enterprise, we successfully develop, procure and produce biological active pharmaceutical ingredients and drug products through all stages of the value chain.</span><br style="color:#666666;text-transform:none;text-indent:0px;letter-spacing:normal;font-family:'Titillium Web', 'Noto Sans', 'sens-serif';font-size:16px;font-style:normal;font-weight:400;word-spacing:0px;white-space:normal;background-color:#ffffff;" /><br style="color:#666666;text-transform:none;text-indent:0px;letter-spacing:normal;font-family:'Titillium Web', 'Noto Sans', 'sens-serif';font-size:16px;font-style:normal;font-weight:400;word-spacing:0px;white-space:normal;background-color:#ffffff;" /><a style="margin:0px;padding:0px;border:0px;color:#0498d7;text-transform:none;text-indent:0px;letter-spacing:normal;font-family:'Titillium Web', 'Noto Sans', 'sens-serif';font-size:16px;font-style:normal;font-weight:400;text-decoration:none;word-spacing:0px;vertical-align:baseline;white-space:normal;background-color:#ffffff;" href="https://www.nordmark-pharma.de/en/business-customers/biochemicals/">Nordmark Pharma GmbH Hopepage =&gt;</a>]]></description>
			<author><![CDATA[seoulin]]></author>
			<pubDate>Thu, 25 Mar 2021 13:46:32 +0000</pubDate>
			<category domain="https://en.seoulin.co.kr/?kboard_redirect=2"><![CDATA[Partners]]></category>
		</item>
				<item>
			<title><![CDATA[SeouLin Bioscience Co., Ltd. awarded scholarships to graduate students at Korea University College of Life Sciences &amp; Biote]]></title>
			<link><![CDATA[https://en.seoulin.co.kr/?kboard_content_redirect=92]]></link>
			<description><![CDATA[<span style="font-family:arial, helvetica, sans-serif;"><strong>SeouLin Bioscience Co., Ltd. awarded scholarships to graduate students at Korea University College of Life Sciences &amp; Biotechnology</strong></span>

<img class="alignnone size-full wp-image-382" src="http://en.seoulin.co.kr/wp-content/uploads/2021/03/202103_%EA%B3%A0%EB%A0%A4%EB%8C%80%EC%9E%A5%ED%95%99%EA%B8%88%EC%88%98%EC%97%AC.jpg" alt="" width="550" height="413" />

<span style="font-family:arial, helvetica, sans-serif;">□ SeouLin Bioscience Co., Ltd. awarded scholarships to five graduate students at Korea University College of Life Sciences &amp; Biotechnology who published excellent thesis in renowned international academic journals.</span>

<span style="font-family:arial, helvetica, sans-serif;">□ SeouLin Bioscience Co., Ltd.(CEO &amp; Chairman Eul-moon Hwang) selected five graduate students of Korea University College of Life Sciences &amp; Biotechnology who published their thesis in renowned international academic journals last year, and awarded scholarships to them through Korea University College of Life Sciences &amp; Biotechnology Support Foundation (Chairman Kim Ik-hwan) on March 10<sup>th</sup>.</span>

<span style="font-family:arial, helvetica, sans-serif;">□ Scholarship recipients and academic journals published thesis with a total of five graduate students, including Sara Kim(Nature Communications), Yeon-kyung Park(Nature Communications), Pavani Dissanayake(Renewable and Sustainable Energy Reviews), Eun-bin Gong(Cell Death &amp; Differentiation), and Yeon-jin Noh(Biosensors and Bioelectronics). The journal that published the thesis is the best journal in the field.</span>

<span style="font-family:arial, helvetica, sans-serif;">□ Eul-moon, Hwang, CEO &amp; Chairman of SeouLin Bioscience Co., Ltd. has contributed to supporting research in the bio field of Korean universities and companies. Through this ceremony, SeouLin Bioscience Co., Ltd. will award special scholarship of about $1,800 each to five graduate students of Korea University College of Life Sciences &amp; Biotechnology who published their thesis in renowned international academic journals. In addition, SeouLin Bioscience Co., Ltd. will continue to contribute to the development of the field of life science through social responsibility activities.</span>

 

<span style="font-family:arial, helvetica, sans-serif;">“<strong>고려대, 서린바이오사이언스와 대학원생 장학금 수여식 진행</strong>”. 파이낸셜투데이. last modified March 10, 2021, accessed March 15, 2021, </span>
<span style="font-family:arial, helvetica, sans-serif;"><strong>http://www.ftoday.co.kr/news/articleView.html?idxno=212103</strong></span>]]></description>
			<author><![CDATA[seoulin]]></author>
			<pubDate>Tue, 16 Mar 2021 16:15:50 +0000</pubDate>
			<category domain="https://en.seoulin.co.kr/?kboard_redirect=1"><![CDATA[SLB NEWS]]></category>
		</item>
				<item>
			<title><![CDATA[SeouLin Bioscience Co., Ltd. participated in Korean Society for Stem Cell Research 2020]]></title>
			<link><![CDATA[https://en.seoulin.co.kr/?kboard_content_redirect=91]]></link>
			<description><![CDATA[<span style="font-family:arial, helvetica, sans-serif;"><strong>SeouLin Bioscience Co., Ltd. </strong><strong>participated in Korean Society for Stem Cell Research 2020</strong></span>

<span style="font-family:arial, helvetica, sans-serif;">SeouLin Bioscience Co., Ltd. participated in Korean Society for Stem Cell Research 2020 held in Swiss Grand Hotel in Hongeun-dong, Seoul, from August 13 to 14, 2020.</span>

<span style="font-family:arial, helvetica, sans-serif;">At the conference held on this period, SeouLin Bioscience Co., Ltd. promoted Bio-products required for cell and cell therapy.</span>

<span style="font-family:arial, helvetica, sans-serif;">Through this conference, it was an opportunity to introduce SeouLin Bioscience Co., Ltd.’s products widely to cell research clients.</span>

<span style="font-family:arial, helvetica, sans-serif;"><span style="font-family:arial, helvetica, sans-serif;"><strong><img class="alignnone size-full wp-image-384" src="http://en.seoulin.co.kr/wp-content/uploads/2021/03/2020-08-13-654x1024-2.jpg" alt="" width="654" height="958" /></strong></span></span>

 ]]></description>
			<author><![CDATA[seoulin]]></author>
			<pubDate>Tue, 16 Mar 2021 16:12:57 +0000</pubDate>
			<category domain="https://en.seoulin.co.kr/?kboard_redirect=1"><![CDATA[SLB NEWS]]></category>
		</item>
				<item>
			<title><![CDATA[SeouLin Bioscience Co., Ltd. participated in KOREA LAB 2020]]></title>
			<link><![CDATA[https://en.seoulin.co.kr/?kboard_content_redirect=90]]></link>
			<description><![CDATA[<span style="font-family:arial, helvetica, sans-serif;"><strong>SeouLin Bioscience Co., Ltd. participated in KOREA LAB 2020</strong></span>

<span style="font-family:arial, helvetica, sans-serif;">SeouLin Bioscience Co., Ltd. participated in the KOREA LAB 2021 Laboratory &amp; Analytical Equipment Exhibition held in KINTEX from July 23 to 30, 2020.</span>

<span style="font-family:arial, helvetica, sans-serif;">The exhibition is known as the largest event in Korea in the field of laboratory technology, analysis, and biotechnology.</span>

<span style="font-family:arial, helvetica, sans-serif;">SeouLin Bioscience Co., Ltd. participated in this exhibition as an exhibitor and introduced brand products such as ecoTree, Cytiva, Axygen, Thermo CCS, Yuhan-Kimberly and Curiosis, etc.</span>

<span style="font-family:arial, helvetica, sans-serif;">There was many interest and support from enterprises, suppliers, government institutions, and laboratory clients showed in our booth.</span>

<img class="size-full wp-image-378 aligncenter" src="http://en.seoulin.co.kr/wp-content/uploads/2021/03/2020-07-27_2.png" alt="" width="431" height="561" />]]></description>
			<author><![CDATA[seoulin]]></author>
			<pubDate>Tue, 16 Mar 2021 16:06:02 +0000</pubDate>
			<category domain="https://en.seoulin.co.kr/?kboard_redirect=1"><![CDATA[SLB NEWS]]></category>
		</item>
				<item>
			<title><![CDATA[BD Biosciences]]></title>
			<link><![CDATA[https://en.seoulin.co.kr/?kboard_content_redirect=89]]></link>
			<description><![CDATA[<p class="large" style="margin:0px 0px 30px;color:#6f6c6c;text-transform:none;line-height:26px;text-indent:0px;letter-spacing:normal;font-family:'FS Albert Pro', Helvetica, Arial, Verdana, sans-serif;font-size:18px;font-style:normal;font-weight:400;word-spacing:0px;white-space:normal;background-color:#ffffff;"><span style="color:#000000;font-family:arial, helvetica, sans-serif;">Leading healthcare safety and technologies for more than a century</span></p>
<p class="large" style="margin:0px 0px 30px;color:#6f6c6c;text-transform:none;line-height:26px;text-indent:0px;letter-spacing:normal;font-family:'FS Albert Pro', Helvetica, Arial, Verdana, sans-serif;font-size:18px;font-style:normal;font-weight:400;word-spacing:0px;white-space:normal;background-color:#ffffff;"><span style="color:#000000;font-family:arial, helvetica, sans-serif;"><span style="color:#000000;font-family:arial, helvetica, sans-serif;">In 1897, Maxwell Becton and Fairleigh Dickinson founded Becton, Dickinson and Company with a vision to improve outcomes for patients. With more than a century of experience and our global reach, BD leads in patient and healthcare worker safety and the technologies that enable medical research and clinical laboratories.</span></span></p>
<a href="https://www.bdbiosciences.com/ko-kr">BD Biosciences Homepage =&gt;</a>]]></description>
			<author><![CDATA[seoulin]]></author>
			<pubDate>Tue, 02 Mar 2021 09:16:39 +0000</pubDate>
			<category domain="https://en.seoulin.co.kr/?kboard_redirect=2"><![CDATA[Partners]]></category>
		</item>
				<item>
			<title><![CDATA[BIOMERIEUX]]></title>
			<link><![CDATA[https://en.seoulin.co.kr/?kboard_content_redirect=88]]></link>
			<description><![CDATA[A global leader in <em>in vitro</em> diagnostics for over 55 years, bioMérieux has always been driven by a pioneering spirit and unrelenting commitment to improve public health worldwide. The Company is present in 44 countries and serves more than 160 countries with the support of a large network of distributors. It provides diagnostic solutions that improve patient health and ensure consumer safety.

<a href="https://www.biomerieux.com/en"><strong>Go BIOMERIEUX Homepage =&gt;</strong></a>]]></description>
			<author><![CDATA[seoulin]]></author>
			<pubDate>Mon, 14 Sep 2020 17:41:40 +0000</pubDate>
			<category domain="https://en.seoulin.co.kr/?kboard_redirect=2"><![CDATA[Partners]]></category>
		</item>
				<item>
			<title><![CDATA[SeouLin Bioscience demonstrated “ecoTree” removes COVID-19 virus by 99.95%]]></title>
			<link><![CDATA[https://en.seoulin.co.kr/?kboard_content_redirect=87]]></link>
			<description><![CDATA[<img class="alignnone size-full wp-image-368" src="http://en.seoulin.co.kr/wp-content/uploads/2020/07/image_readtop_2020_764969_15958122364294371.jpg" alt="" width="1000" height="409" />

<span style="font-family:arial, helvetica, sans-serif;font-size:14pt;">SeouLin Bioscience, a company providing eco-friendly sanitation &amp; sterilization solutions, announced on July 27<sup>th</sup> that the sterilizing water generated by “ecoTree” kills COVID-19 virus about 99.95% in 30 seconds.</span>

<span style="font-family:arial, helvetica, sans-serif;font-size:14pt;">The sterilizing water generated by “ecoTree” is slightly acidic Hypochlorous acid(HOCl) which has a wide range of sterilizing effects on germs, viruses and algae. It is used in the food industry, agriculture, medical devices, and other areas around the world.</span>

<span style="font-family:arial, helvetica, sans-serif;font-size:14pt;">In addition to the COVID-19 sterilization test, ‘ecoTree’ has verified safety and sterilization power against harmful microorganism. The safety for the human body was verified through the Acute Eye Irritation Test and Acute Oral Toxicity Test. Through the test results of the Korea Testing &amp; Research Institute, it proved the sterilization power against 12 kinds of harmful microorganisms (E. coli, Staphylococcus aureus, Salmonella, Vibrio, Bacillus cereus, Listeria, Rhizopus, Aspergillus, Saccharomyces, Serratia, Candida, and Pseudomonas aeruginosa).</span>

<span style="font-family:arial, helvetica, sans-serif;font-size:14pt;">“ecoTree” is being used for sanitation management at many places including five KTX stations, public health centers, port authorities, universities, enterprises and government research centers such as the Korea Ministry of Food and Drug Safety and the Korea Centers for Disease Control and Prevention. SeouLin Bioscience also sells sterilizing water products that meets the standards of the Korea Ministry of Environment and the Korea Ministry of Food and Drug Safety.</span>

<span style="font-family:arial, helvetica, sans-serif;font-size:14pt;">Eul-Moon Hwang, CEO of SeouLin Bioscience, said, “We will contribute to management of self- immune and prevention in daily life for public safety based on the “ecoTree” COVID-19 test result.”</span>

<span style="font-family:arial, helvetica, sans-serif;font-size:14pt;">“서린바이오, ‘에코트리’ 코로나19 바이러스 99.95% 사멸 효과 입증”. 매일경제. last modified July 27, 2020, accessed July 28, 2020, </span><a href="https://www.mk.co.kr/news/stock/view/2020/07/764969/">https://www.mk.co.kr/news/stock/view/2020/07/764969/</a>

<img class="alignnone size-full wp-image-370" src="http://en.seoulin.co.kr/wp-content/uploads/2020/07/COVID19-%ED%85%8C%EC%8A%A4%ED%8A%B8-%EC%98%81%EB%AC%B8.jpg" alt="" width="574" height="817" />]]></description>
			<author><![CDATA[seoulin]]></author>
			<pubDate>Wed, 29 Jul 2020 18:11:45 +0000</pubDate>
			<category domain="https://en.seoulin.co.kr/?kboard_redirect=1"><![CDATA[SLB NEWS]]></category>
		</item>
				<item>
			<title><![CDATA[SeouLin Bioscience supplies ‘ecoTree’ sterilization water generator, a big role in the prevention of living]]></title>
			<link><![CDATA[https://en.seoulin.co.kr/?kboard_content_redirect=86]]></link>
			<description><![CDATA[<img class="wp-image-363 aligncenter" src="http://en.seoulin.co.kr/wp-content/uploads/2020/06/0004596217_001_20200616125704696.jpg" alt="" width="553" height="407" />

<span style="font-family:arial, helvetica, sans-serif;">Amid the spread of COVID-19, the cases of sanitation by citizens using ecoTree, the sterilization &amp; sanitation solution from SeouLin Bioscience, is increasing.</span>

<span style="font-family:arial, helvetica, sans-serif;">According to SeouLin Bioscience on June 16th, ecoTree SLB-120, the sterilization water generator, was installed at the community service center in Hwado-Su-dong, Namyangju-si, Gyeonggi-do city, allowing citizens to receive sterilization water for free. This contributes to the prevention of living for the citizens.</span>

<span style="font-family:arial, helvetica, sans-serif;">ecoTree SLB-120 has also been set up at the community service center in Dongtan 4-dong, and Dasan-dong, Hwaseong-si, Gyeonggi-do city, to offer many local citizens using sterilization water for free.</span>

<span style="font-family:arial, helvetica, sans-serif;">ecoTree SLB-120, the sterilization water generator, can sterilize 12 different kinds of harmful bacteria, including E.coli, Staphylococcus aureus, Salmonella, Vibrio and Pseudomonas aeruginosa with its Hypochlorous acid(HOCl) which is the strong and safe sterilizer</span>

<span style="font-family:arial, helvetica, sans-serif;">ecoTree SLB-120 is used for sanitation &amp; sterilization at KTX stations, public health centers, as well as Korea Ministry of Food and Drug Safety, Korea Centers for Disease Control and Prevention, government research centers, universities, and enterprises.</span>

<span style="font-family:arial, helvetica, sans-serif;">An official from SeouLin Bioscience said, “Recently, the exports of ecoTree SLB-120 have proceeded to many countries such as Thailand, Canada, Germany, U.S., Spain, Japan, Brazil, Australia, and Zimbabwe.”</span>

<span style="font-family:arial, helvetica, sans-serif;">“<strong>서린바이오, 살균수 제조장치 `에코트리` 보급…생활방역에 큰 역할.” 매일경제. last modified June 16, 2020, accessed June 23, 2020, </strong></span><a href="https://n.news.naver.com/article/009/0004596217">https://n.news.naver.com/article/009/0004596217</a>]]></description>
			<author><![CDATA[seoulin]]></author>
			<pubDate>Wed, 24 Jun 2020 13:27:48 +0000</pubDate>
			<category domain="https://en.seoulin.co.kr/?kboard_redirect=1"><![CDATA[SLB NEWS]]></category>
		</item>
				<item>
			<title><![CDATA[SeouLin Bioscience signed export contracts for Sterilization Water Generator]]></title>
			<link><![CDATA[https://en.seoulin.co.kr/?kboard_content_redirect=85]]></link>
			<description><![CDATA[SeouLin Bioscience, a specialized company for Sterilization &amp; Sanitation solution announced on April 20th that the company signed contract to export ‘Sterilization Water Generator (ecoTree SLB-120)’.
SeouLin Bioscience has expanded the market for Sterilization Water Generator including local health centers, city hall, port authority and KTX stations in Korea. Recently, it has also been used for facility management for the prevention of COVID-19 and for the purpose of supporting sterilizing water to publics.
A company official said, “We have started exporting to Germany, U.S., Canada and Thailand. Export inquiries have continued from foreign states such as Japan, Australia, France, Spain, Egypt and Indonesia.”
According to the company, in the first quarter of this year, the domestic sales of Sterilization Water Generator increased by 130% compared to the annual sales volume last year, and the sales of sterilized water surged by 3,000% compared to the total sales of last year.
An official from SeouLin Bioscience said, “We will expand our export base by expanding the product lineup of Sterilization Water Generator to tap overseas market.”]]></description>
			<author><![CDATA[seoulin]]></author>
			<pubDate>Fri, 24 Apr 2020 10:01:25 +0000</pubDate>
			<category domain="https://en.seoulin.co.kr/?kboard_redirect=1"><![CDATA[SLB NEWS]]></category>
		</item>
				<item>
			<title><![CDATA[SeouLin Bioscience Co. Ltd., invests in overseas new drug development company for cancer vaccine]]></title>
			<link><![CDATA[https://en.seoulin.co.kr/?kboard_content_redirect=84]]></link>
			<description><![CDATA[SeouLin Bioscience Co. Ltd., invests in overseas new drug development company for cancer vaccine
 
On March 18, SeouLin Bioscience announced that it will invest $ 3.6 million in XEME Biopharma (below XEME), a new drug development company for cancer vaccine located in Illinois US.
Since its founding in 2005, XEME has been recognized for its unique cancer vaccine platform by the National Cancer Center and the US Food and Drug Administration (FDA) for 15 years. Currently in Phase 2 clinical trials. XEME explained that it has developed a unique platform for a personalized cancer treatment vaccine that uses its entire cancer cell as an antigen, which is also available for treatment and prevention of blood cancer, solid cancer and coronavirus in parallel with existing immuno-cancer drugs and latest anti-cancer treatments.
With the agreement, SeouLin Bioscience signed a memorandum of understanding(MOU) with XEME’s parent company, R2T. Through the signing of the MOU, the two companies agreed to actively cooperate for the marketing and distribution of XEME's cancer vaccine technology and the sale of R2T's unique dry treatment formula.
Through these contracts, we want to advance into the market for cancer vaccines and immunotherapy products for treatment, equip ourselves with new momentum, and contribute to improving human health and quality of life, said Eul-moon, Hwang, CEO of SeouLin Bioscience.]]></description>
			<author><![CDATA[seoulin]]></author>
			<pubDate>Tue, 14 Apr 2020 10:04:20 +0000</pubDate>
			<category domain="https://en.seoulin.co.kr/?kboard_redirect=1"><![CDATA[SLB NEWS]]></category>
		</item>
			</channel>
</rss>